Pacira Pharmaceuticals (PCRX)

Add to Watchlists
Create an Alert
35.55 +0.20  +0.57% NASDAQ May 25, 20:00 Delayed 2m USD

Pacira Pharmaceuticals Free Cash Flow (Quarterly):

-7.873M for March 31, 2018
View 4,000+ financial data types
View Full Chart

Pacira Pharmaceuticals Free Cash Flow (Quarterly) Chart

Export Data
Save Image
Print Image

Pacira Pharmaceuticals Historical Free Cash Flow (Quarterly) Data

View and export this data going back to 2009. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2018 -7.873M
Dec. 31, 2017 11.86M
Sept. 30, 2017 -8.227M
June 30, 2017 -1.499M
March 31, 2017 -3.61M
Dec. 31, 2016 12.47M
Sept. 30, 2016 7.778M
June 30, 2016 -1.327M
March 31, 2016 -10.17M
Dec. 31, 2015 7.911M
Sept. 30, 2015 -6.787M
June 30, 2015 -4.654M
March 31, 2015 -8.744M
Dec. 31, 2014 5.899M
Sept. 30, 2014 4.03M
June 30, 2014 2.195M
March 31, 2014 -8.544M
Dec. 31, 2013 -9.706M
Sept. 30, 2013 -14.53M
June 30, 2013 -15.05M
March 31, 2013 -16.72M
Dec. 31, 2012 -25.91M
Sept. 30, 2012 -17.44M
June 30, 2012 -24.60M
March 31, 2012 -20.45M
Dec. 31, 2011 -10.08M
Sept. 30, 2011 -10.14M
June 30, 2011 -12.13M
March 31, 2011 -4.819M
Dec. 31, 2010 -8.788M
Sept. 30, 2010 -8.812M
June 30, 2010 -10.04M
March 31, 2010 -4.013M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Free Cash Flow

Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

According to many investors, free cash flow is the best indication of a company's ability to generate cash.
Learn More


PCRX Free Cash Flow (Quarterly) Benchmarks

Enanta Pharmaceuticals -8.33M
Heron Therapeutics -62.62M
Arena Pharmaceuticals -30.10M

PCRX Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum -15.05M Jun 2013
Maximum 12.47M Dec 2016
Average -2.430M

PCRX Free Cash Flow (Quarterly) Excel Add-In Codes

  • Metric Code: free_cash_flow
  • Latest data point: =YCP("PCRX", "free_cash_flow")
  • Last 5 data points: =YCS("PCRX", "free_cash_flow", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.